A higher dose of anti-T-lymphocyte globulin (ATLG) significantly outperformed a lower dose in preventing graft-vs-host disease (GVHD) in patients receiving matched –sibling donor (MSD) peripheral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results